JDVCX
Price
$16.65
Change
+$0.04 (+0.24%)
Updated
Oct 17 closing price
Net Assets
491.99M
RLBCX
Price
$38.75
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

JDVCX vs RLBCX

Header iconJDVCX vs RLBCX Comparison
Open Charts JDVCX vs RLBCXBanner chart's image
JPMorgan Diversified C
Price$16.65
Change+$0.04 (+0.24%)
VolumeN/A
Net Assets491.99M
American Funds American Balanced R3
Price$38.75
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
JDVCX vs RLBCX Comparison Chart in %
View a ticker or compare two or three
VS
JDVCX vs. RLBCX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDVCX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 265B vs. JDVCX (492M). JDVCX pays higher dividends than RLBCX: JDVCX (2.15) vs RLBCX (1.49). JDVCX was incepted earlier than RLBCX: JDVCX (23 years) vs RLBCX (23 years). JDVCX (1.74) is less costly to investors than RLBCX (0.89). JDVCX is a more actively managed with annual turnover of: 83.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than JDVCX: RLBCX (250) vs JDVCX (1000). RLBCX annual gain was more profitable for investors over the last year : 8.34 vs. JDVCX (6.66). RLBCX return over 5 years is better than : 40.24 vs. JDVCX (4.58).
JDVCXRLBCXJDVCX / RLBCX
Total Expense Ratio1.460.89164%
Annual Report Gross Expense Ratio1.740.89196%
Fund Existence23 years23 years-
Gain YTD11.00414.36477%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets492M265B0%
Annual Yield % from dividends2.151.49144%
Returns for 1 year6.668.3480%
Returns for 3 years35.3249.2672%
Returns for 5 years4.5840.2411%
Returns for 10 years15.7972.1822%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBM3.520.07
+2.03%
Psyence Biomedical Ltd
CVGW23.810.14
+0.59%
Calavo Growers
SWK67.85-0.06
-0.09%
Stanley Black & Decker
IQ2.03-0.03
-1.46%
iQIYI
PMVP1.40-0.04
-2.78%
PMV Pharmaceuticals